UBS Group’s Silicon Laboratories SLAB Stock Holding History

UBS Group’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,600	Closed	-$1.02M	–	8128
2017 Q4	$1.02M	Buy	+11,600	New	+$1.04M	﹤0.01%	3768

Other funds holding SLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group's SLAB Position: Q2 2026 in Review

UBS Group increased its Silicon Laboratories (SLAB) stake by 102% in Q2 2026, buying an estimated $84M and bringing the position to 769,780 shares worth $168M. The position accounts for 0.02% of the portfolio, ranked #770.

UBS Group first reported a position in SLAB in Q4 2014 and has held it in 47 quarters since. 353 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

UBS Group held 769,780 shares of Silicon Laboratories worth $168M as of Q2 2026.
UBS Group bought 388,624 Silicon Laboratories shares in Q2 2026, an estimated $84M.
Silicon Laboratories made up 0.02% of UBS Group's portfolio in Q2 2026, its #770 holding.
UBS Group first reported a position in Silicon Laboratories in Q4 2014 and has held it in 47 quarters since.
353 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.